These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 498695)
1. Naphthoxylactic acid after single and long-term doses of propranolol. Walle T; Conradi EC; Walle UK; Fagan TC; Gaffney TE Clin Pharmacol Ther; 1979 Nov; 26(5):548-54. PubMed ID: 498695 [No Abstract] [Full Text] [Related]
2. Measurement of naphthoxylactic and naphtoxyacetic acid in human plasma following propranolol administration. Pritchard F; Schneck D; Hayes A Res Commun Chem Pathol Pharmacol; 1979 Feb; 23(2):279-86. PubMed ID: 461953 [TBL] [Abstract][Full Text] [Related]
3. O-methylated catechol-like metabolites of propranolol in man. Walle T; Conradi EC; Walle UK; Gaffney TE Drug Metab Dispos; 1978; 6(4):481-7. PubMed ID: 28930 [TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of naphthoxylactic acid, a major metabolite of propranolol in plasma in man. Easterling DE; Walle T; Conradi EC; Gaffney TE J Chromatogr; 1979 Mar; 162(3):439-45. PubMed ID: 528611 [No Abstract] [Full Text] [Related]
5. Propranolol, propranolol glucuronide, and naphthoxylactic acid in breast milk and plasma. Smith MT; Livingstone I; Hooper WD; Eadie MJ; Triggs EJ Ther Drug Monit; 1983; 5(1):87-93. PubMed ID: 6845404 [TBL] [Abstract][Full Text] [Related]
6. Selective induction of propranolol metabolism by smoking: additional effects on renal clearance of metabolites. Walle T; Walle UK; Cowart TD; Conradi EC; Gaffney TE J Pharmacol Exp Ther; 1987 Jun; 241(3):928-33. PubMed ID: 3598909 [TBL] [Abstract][Full Text] [Related]
8. Propranolol metabolism in normal subjects: association with sex steroid hormones. Walle T; Walle K; Mathur RS; Palesch YY; Conradi EC Clin Pharmacol Ther; 1994 Aug; 56(2):127-32. PubMed ID: 8062488 [TBL] [Abstract][Full Text] [Related]
9. Variable first-pass elimination of propranolol following single and multiple oral doses in hypertensive patients. Wargin WA; Sawchuk RJ; McBride JW; McCoy HG; Rylander ML Eur J Drug Metab Pharmacokinet; 1982; 7(3):183-9. PubMed ID: 7173272 [TBL] [Abstract][Full Text] [Related]
10. [Comparative pharmacokinetic studies on the relative biologic availability of two propranolol preparations in patients with steady state essential hypertension]. Rostock G; Faulhaber HD; Gohlke HR; Prehm C Pharmazie; 1986 Apr; 41(4):258-60. PubMed ID: 3725870 [TBL] [Abstract][Full Text] [Related]
11. Propranolol in pregnancy three year prospective study. Livingstone I; Craswell PW; Bevan EB; Smith MT; Eadie MJ Clin Exp Hypertens B; 1983; 2(2):341-50. PubMed ID: 6872291 [TBL] [Abstract][Full Text] [Related]
12. The influence of diltiazem versus cimetidine on propranolol metabolism. Tateishi T; Ohashi K; Fujimura A; Ebihara A J Clin Pharmacol; 1992 Dec; 32(12):1099-104. PubMed ID: 1487547 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and identification of 3-(4-hydroxy-1-naphthoxy)lactic acid as a metabolite of propranolol in the rat, in man, and in the rat liver 9000 g supernatant fraction. Talaat RE; Nelson WL Drug Metab Dispos; 1986; 14(2):202-7. PubMed ID: 2870895 [TBL] [Abstract][Full Text] [Related]
14. Propranolol in hypertension: a dose-response study. Galloway DB; Glover SC; Hendry WG; Logie AW; Petrie JC; Smith MC; Lewis JA; Simpson WT Br Med J; 1976 Jul; 2(6028):140-2. PubMed ID: 776351 [TBL] [Abstract][Full Text] [Related]
15. Massive propranolol metabolite retention during maintenance hemodialysis. Stone WJ; Walle T Clin Pharmacol Ther; 1980 Oct; 28(4):449-55. PubMed ID: 7408404 [TBL] [Abstract][Full Text] [Related]
16. Propranolol therapy in essential hypertension. Observations on predictability of therapeutic response. Hansson L; Zweifler AJ; Julius S; Ellis CN Int J Clin Pharmacol; 1974 Sep; 10(2):79-89. PubMed ID: 4448555 [No Abstract] [Full Text] [Related]